Related references
Note: Only part of the references are listed.Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
Carlota Dobano et al.
TRANSLATIONAL RESEARCH (2022)
Low-Complexity Repetitive Epitopes of Plasmodium falciparum Are Decoys for Humoural Immune Responses
Nan Hou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses
Jenna J. Guthmiller et al.
IMMUNITY (2020)
Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia
Marijana Stojanovic et al.
VACCINES (2020)
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/ASO1E malaria vaccine efficacy
Carlota Dobano et al.
NATURE COMMUNICATIONS (2019)
RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study
Carlota Dobano et al.
BMC MEDICINE (2019)
Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
Babita Agrawal
FRONTIERS IN IMMUNOLOGY (2019)
Would immunization be the same without cross-reactivity?
Ivo Vojtek et al.
VACCINE (2019)
Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination
Carlota Dobano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Convalescent Plasmodium falciparum-specific seroreactivity does not correlate with paediatric malaria severity or Plasmodium antigen exposure
Anne Kessler et al.
MALARIA JOURNAL (2018)
Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein in Pregnant Women Are Associated with Higher Birth Weight in a Multicenter Study
Pilar Requena et al.
FRONTIERS IN IMMUNOLOGY (2017)
Malaria Parasites: The Great Escape
Laurent Renia et al.
FRONTIERS IN IMMUNOLOGY (2016)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
H. Tinto et al.
LANCET (2015)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Michael T. White et al.
LANCET INFECTIOUS DISEASES (2015)
RTS,S Vaccination Is Associated With Serologic Evidence of Decreased Exposure to Plasmodium falciparum Liver- and Blood-Stage Parasites
Joe J. Campo et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
Michael T. White et al.
BMC MEDICINE (2014)
A small jab - a big effect: nonspecific immunomodulation by vaccines
Christine S. Benn et al.
TRENDS IN IMMUNOLOGY (2013)
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
Sara Mian-McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children
Philip Bejon et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact of the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody Responses to Multiple Asexual Blood Stage Antigens
Joseph J. Campo et al.
PLOS ONE (2011)
Abundance of intrinsically unstructured proteins in P-falciparum and other apicomplexan parasite proteomes
Zhi-Ping Feng et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2006)
Profiling the humoral immune response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery
DH Davies et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
